The trade-off is less clinical trial data and no FDA approval
GLP-1 therapy as a science backed appetite tool If your food based strategy still leaves you battling constant hunger, GLP-1 for weight loss can be a meaningful next step
O risco no reside, portanto, numa nica substncia, mas na natureza multiplicativa da stack
Mechanistically, an expanding body of preclinical/translational research suggests that the gut-microbiome impacts breast carcinogenesis and therapy through several interrelated pathways-chiefly in terms of its estrobolome (microbial pool of genes dedicated to estrogen metabolism), bioactive microbial metabolite synthesis, systemic/mucosal immunity modulation (influencing T-cell subsets/myeloid cell function/inflammatory cytokine networks) also together with drug pharmacokinetics/pharmacodynamics (175)
Haenssle HA, Blum A, Hofmann-Wellenhof R, Kreusch J, Stolz W, Argenziano G, et al